{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:12:27Z","timestamp":1760235147770,"version":"build-2065373602"},"reference-count":79,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Novel coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a worldwide pandemic and affected more than 227 countries or territories, resulting in more than 179 million cases with over 3.890.00 deaths, as of June 25, 2021. The Hellenic Thoracic Society (HTS) during the second wave of COVID-19 pandemic released a guidance document for the management of patients with COVID-19 in the community and in hospital setting. In this review, with guidance the HTS document, we are discussing the outpatient management of COVID-19 patients, including the preventive measures, the patients\u2019 isolation and quarantine criteria of close contacts, the severity and risk stratification, including the decisions for advanced hospitalization, and the disease management at home in patients with mild disease and after hospital discharge for those with more severe disease.<\/jats:p>","DOI":"10.3390\/jpm11080709","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T22:06:21Z","timestamp":1627250781000},"page":"709","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outpatient Management of COVID-19 Disease: A Holistic Patient-Centered Proposal Based on the Greek Experience"],"prefix":"10.3390","volume":"11","author":[{"given":"Adamantia","family":"Liapikou","sequence":"first","affiliation":[{"name":"6th Respiratory Department, Sotiria Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Tzortzaki","sequence":"additional","affiliation":[{"name":"Respiratory Outpatient Clinic, Heraklion, 71305 Crete, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Hillas","sequence":"additional","affiliation":[{"name":"5th Respiratory Department, Sotiria Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miltiadis","family":"Markatos","sequence":"additional","affiliation":[{"name":"Respiratory Outpatient Clinic, Heraklion, 71305 Crete, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1391-2925","authenticated-orcid":false,"given":"Ilias C.","family":"Papanikolaou","sequence":"additional","affiliation":[{"name":"Pulmonary Department, Sarcoidosis Clinic, General Hospital of Corfu, 49100 Corfu, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0774-3942","authenticated-orcid":false,"given":"Konstantinos","family":"Kostikas","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Department, University Hospital of Ioannina, 45500 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"ref_1","unstructured":"(2021, June 01). Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.mayocp.2020.04.010","article-title":"The Early Natural History of SARS-CoV-2 Infection: Clinical Observations From an Urban, Ambulatory COVID-19 Clinic","volume":"95","author":"Cohen","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.medin.2020.06.015","article-title":"Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia, Spain","volume":"45","author":"Villarreal","year":"2021","journal-title":"Med. Intensiva."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1513\/AnnalsATS.202003-225OC","article-title":"Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China","volume":"17","author":"Du","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_6","unstructured":"(2021, June 24). Available online: https:\/\/eody.gov.gr\/wp-content\/uploads\/2021\/06\/covid-gr-daily-report-20210624.pdf."},{"key":"ref_7","unstructured":"(2021, March 08). Available online: https:\/\/hts.org.gr\/assets\/files\/news\/COVID_home_care_updated_plusafterhospitalcare.pdf."},{"key":"ref_8","unstructured":"(2021, July 16). Available online: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-COVID-19\/treatments-vaccines\/treatments-COVID-19\/COVID-19-treatments-under-evaluation."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bhimraj, A., Morgan, R., Shumaker, A.H., Lavergne, V., Baden, L., Cheng, V.C.-C., Edwards, K.M., Gandhi, R., Muller, W.J., and O\u2019Horo, J.C. (2020). Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin. Infect. Dis., ciaa478.","DOI":"10.1093\/cid\/ciaa478"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/resp.14060","article-title":"Letter from Greece","volume":"26","author":"Kostikas","year":"2021","journal-title":"Respirology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"00468","DOI":"10.1183\/23120541.00468-2020","article-title":"Primary care and COVID-19: Cutting the Gordian knot\u2014The Greek experience and algorithm","volume":"6","author":"Tomos","year":"2020","journal-title":"ERJ Open Res."},{"key":"ref_12","unstructured":"WHO (2020). Coronavirus Disease (COVID-19) Advice for the Public: When and How to Use Masks, WHO. WHO Last Report Updated."},{"key":"ref_13","unstructured":"Centers for Disease Control and Prevention (2021). Your Guide to Masks, CDC Report Updated."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2001260","DOI":"10.1183\/13993003.01260-2020","article-title":"Universal use of face masks for success against COVID-19: Evidence and implications for prevention policies","volume":"55","author":"Esposito","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/thoraxjnl-2020-215748","article-title":"Face coverings and mask to minimise droplet dispersion and aerosolization: A video case study","volume":"75","author":"Bahl","year":"2020","journal-title":"Thorax"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(20)31142-9","article-title":"Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: A systematic review and meta-analysis","volume":"395","author":"Chu","year":"2020","journal-title":"Lancet"},{"key":"ref_18","unstructured":"Centers for Disease Control and Prevention (2021). When You\u2019ve Been Fully Vaccinated. How to Protect Yourself and Others, CDC Report Updated."},{"key":"ref_19","unstructured":"Center for Disease Control and Prevention (CDC) (2020). Handwashing in Community Settings, When and How to Wash Your Hands, CDC Report Updated."},{"key":"ref_20","unstructured":"Center for Disease Control and Prevention (CDC) (2021). Cleaning, Disinfecting, and Ventilation."},{"key":"ref_21","unstructured":"National Public Health Organization of Greece (EODY) (2021). Quarantine and Isolation Ending Strategy in Close Contacts and Patients of COVID-19, Technical Report, 22\/4\/21."},{"key":"ref_22","unstructured":"European Centre for Disease Prevention and Control (2020). Guidance for Discharge and Ending of Isolation of People with COVID-19, European Centre for Disease Prevention and Control. Technical Report, 16\/10\/20."},{"key":"ref_23","unstructured":"Hellenic Thoracic Society (2020). Suggested at Home Management of a Suspected or Confirmed Patient with COVID-19, Hellenic Thoracic Society. Technical Report, 2\/12\/20."},{"key":"ref_24","first-page":"CD013574","article-title":"Quarantine alone or in combination with other public health measures to control COVID-19: A rapid review","volume":"4","author":"Mayr","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_25","first-page":"1","article-title":"Presenting Characteristics Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area","volume":"10022","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Davin-Casalena, B., Jardin, M., Guerrera, H., Mabille, J., Tr\u00e9hard, H., Lapalus, D., M\u00e9nager, C., Nauleau, S., Cassaro, V., and Verger, P. (2021). The impact of the COVID-19 pandemic on first-line primary care in southeastern France: Feedback on the implementation of a real-time monitoring system based on regional health insurance data. Rev. Epidemiol. Sante Publique.","DOI":"10.1016\/j.respe.2021.07.006"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/acem.14053","article-title":"Novel Use of Home Pulse Oximetry Monitoring in COVID-19 Patients Discharged From the Emergency Department Identifies Need for Hospitalization","volume":"27","author":"Shah","year":"2020","journal-title":"Acad. Emerg. Med."},{"key":"ref_28","unstructured":"(2021, June 29). Available online: https:\/\/www.uptodate.com\/contents\/COVID-19-outpatient-evaluation-and-management-of-acute-illness-inadults?search=undefined&source=COVID19_landing&usage_type=main_section."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e046282","DOI":"10.1136\/bmjopen-2020-046282","article-title":"Diagnostic accuracy of subjective dyspnoea in detecting hypoxaemia among outpatients with COVID-19: A retrospective cohort study","volume":"11","author":"Berezin","year":"2021","journal-title":"BMJ Open"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e2015957","DOI":"10.1001\/jamanetworkopen.2020.15957","article-title":"Risk Factors Associated With Mortality Among Residents With Coronavirus Disease 2019 (COVID-19) in Long-term Care Facilities in Ontario, Canada","volume":"3","author":"Fisman","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_31","unstructured":"Centers for Disease Control and Prevention (2021, April 05). Underlying Medical Conditions Associated with High Risk for Severe COVID-19: Information for Healthcare Providers, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-care\/underlyingconditions.html."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e2029058","DOI":"10.1001\/jamanetworkopen.2020.29058","article-title":"Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19","volume":"3","author":"Rosenthal","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa2021801","article-title":"A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of COVID-19","volume":"384","author":"Ubals","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/s41467-021-22446-z","article-title":"Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials","volume":"12","author":"Axfors","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e2013136","DOI":"10.1001\/jamanetworkopen.2020.13136","article-title":"Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized with Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial","volume":"3","author":"Deftereos","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","article-title":"Coalition COVID-19 Brazil I Investigators. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate COVID-19","volume":"383","author":"Cavalcanti","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group (2020). Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19. N. Engl. J. Med., 383, 2030\u20132040.","DOI":"10.1056\/NEJMoa2022926"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for COVID-19","volume":"383","author":"Boulware","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1001\/jama.2021.3071","article-title":"Effect of Ivermectin on Time to Resolution of Symptoms Among Adults with Mild COVID-19: A Randomized Clinical Trial","volume":"325","author":"Hurtado","year":"2021","journal-title":"JAMA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"100720","DOI":"10.1016\/j.eclinm.2020.100720","article-title":"The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial","volume":"32","author":"Chaccour","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e210369","DOI":"10.1001\/jamanetworkopen.2021.0369","article-title":"Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs. Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial","volume":"4","author":"Thomas","year":"2021","journal-title":"JAMA Netw. Open."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2020.22760","article-title":"Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients with Symptomatic COVID-19: A Randomized Clinical Trial","volume":"324","author":"Lenze","year":"2020","journal-title":"JAMA"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Tada, T., Dcosta, B.M., Zhou, H., Vaill, A., Kazmierski, W., and Landau, N.R. (2021). Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies. bioRxiv.","DOI":"10.1101\/2021.02.18.431897"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"PRINCIPLE Trial Collaborative Group (2021). Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): A randomised, controlled, open-label, adaptive platform trial. Lancet, 397, 1063\u20131074.","DOI":"10.1016\/S0140-6736(21)00461-X"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1055\/s-0040-1715798","article-title":"Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology\/Vascular Medicine","volume":"120","author":"Gerotziafas","year":"2020","journal-title":"Thromb. Haemost."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa2029849","article-title":"SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with COVID-19","volume":"384","author":"Chen","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_49","first-page":"1919285","article-title":"501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimab in vitro","volume":"13","author":"Liu","year":"2021","journal-title":"bioRxiv"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e216468","DOI":"10.1001\/jamanetworkopen.2021.6468","article-title":"Effect of Early Treatment with Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial","volume":"4","author":"Reis","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2213-2600(20)30566-X","article-title":"Peginterferon lambda for the treatment of outpatients with COVID-19: A phase 2, placebo-controlled randomised trial","volume":"9","author":"Feld","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_52","first-page":"2021","article-title":"Colchicine for community-treated patients with COVID-19 (COLCORONA): A phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial","volume":"27","author":"Tardif","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Manenti, L., Maggiore, U., Fiaccadori, E., Meschi, T., Antoni, A.D., Nouvenne, A., Ticinesi, A., Cerundolo, N., Prati, B., and Delsante, M. (2021). Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248276"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S2213-2600(21)00160-0","article-title":"Inhaled budesonide in the treatment of early COVID-19 (STOIC): A phase 2, open-label, randomized controlled trial","volume":"9","author":"Ramakrishnan","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.2021.0202","article-title":"Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab on Viral Load in Patients with Mild to Moderate COVID-19: A Randomized Clinical Trial","volume":"325","author":"Gottlieb","year":"2021","journal-title":"JAMA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"Trial Investigators. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19","volume":"384","author":"Weinreich","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_57","unstructured":"(2021, February 25). Fact Sheet for Health Care Providers Emergency Use Authorization (eua) of Bamlamivimab and Etesevimab, Available online: https:\/\/ww.fda.gov\/media\/145802\/download."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group (2021). Dexamethasone in Hospitalized Patients with COVID-19. N. Engl. J. Med., 384, 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ahj.2021.02.001","article-title":"Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study","volume":"235","author":"Capell","year":"2021","journal-title":"Am. Heart J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-020-04678-4","article-title":"Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): A structured summary of a study protocol for a randomized controlled trial","volume":"21","author":"Barco","year":"2020","journal-title":"Trials"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2020.08.070","article-title":"Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19","volume":"76","author":"Piazza","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.chest.2020.05.559","article-title":"Prevention, Diagnosis, and Treatment of VTE in Patients with Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report","volume":"158","author":"Moores","year":"2020","journal-title":"Chest"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/thoraxjnl-2020-215314","article-title":"Respiratory follow-up of patients with COVID-19 pneumonia","volume":"75","author":"George","year":"2020","journal-title":"Thorax"},{"key":"ref_64","unstructured":"Ecdc Tehnical Report (2020, October 16). Novel Coronavirus (SARS-CoV-2) Discharge Criteria for Confirmed COVID-19 cases\u2014When Is It Safe to Discharge COVID-19 Cases from the Hospital or End Home Isolation?. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/COVID-19 Discharge-criteria.pdf."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jvsv.2020.08.030","article-title":"Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection","volume":"9","author":"Obi","year":"2021","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"ref_66","first-page":"167","article-title":"COVID-19 and haemostasis: A position paper from Italian Society on Thrombosis and Haemostasis (SISET)","volume":"18","author":"Marietta","year":"2020","journal-title":"Blood Transfus."},{"key":"ref_67","unstructured":"(2020, May 06). COVID-19 and VTE\/Anticoagulation: Frequently Asked Questions. Available online: https:\/\/www.hematology.org\/COVID-19\/COVID-19-and-vteanticoagulation."},{"key":"ref_68","unstructured":"National Institutes of Health (2021). COVID-19 Treatment Guidelines. Antithrombotic Therapy in Patients With COVID-19."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1055\/s-0040-1705137","article-title":"Modified IMPROVE VTE risk score and elevated D-dimer identify a high venous thromboembolism risk in acutely ill medical population for extended thromboprophylaxis","volume":"4","author":"Spyropoulos","year":"2020","journal-title":"TH Open"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJMoa1601747","article-title":"Extended thromboprophylaxis with betrixaban in acutely ill medical patients","volume":"375","author":"Cohen","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_71","unstructured":"National Institute for Health and Care Excellence (2020). COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19, National Institute for Health and Care Excellence."},{"key":"ref_72","unstructured":"Centers for Disease Control and Prevention (2021). Post-COVID Conditions: Information for Healthcare Providers."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2040622320976979","DOI":"10.1177\/2040622320976979","article-title":"The neurological symptoms of COVID-19: A systematic overview of systematicreviews, comparison with other neurological conditions and implications for healthcare services","volume":"12","author":"Wildwing","year":"2021","journal-title":"Ther. Adv. Chronic. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1589\/jpts.32.545","article-title":"Summary of respiratory rehabilitation and physical therapy guidelines for patients with COVID-19 based on recommendations of World Confederation for Physical Therapy and National Association of Physical Therapy","volume":"32","author":"Zhu","year":"2020","journal-title":"J. Phys. Ther. Sci."},{"key":"ref_75","unstructured":"(2020, April 28). Available online: https:\/\/www.paho.org\/en\/documents\/rehabilitation-considerations-during-covid-19-outbreak."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2003448","DOI":"10.1183\/13993003.03448-2020","article-title":"Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19","volume":"57","author":"Lerum","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"The Writing Committee for the COMEBAC Study Group (2021). Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA, 325, 1525\u20131534.","DOI":"10.1001\/jama.2021.3331"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1513\/AnnalsATS.202008-1002OC","article-title":"Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment","volume":"18","author":"Myall","year":"2021","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_79","unstructured":"(2021, July 20). Available online: https:\/\/ourworldindata.org\/mortality-risk-covid#what-do-we-know-about-the-risk-of-dying-from-covid-19."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/8\/709\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:34:15Z","timestamp":1760164455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/8\/709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":79,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["jpm11080709"],"URL":"https:\/\/doi.org\/10.3390\/jpm11080709","relation":{},"ISSN":["2075-4426"],"issn-type":[{"type":"electronic","value":"2075-4426"}],"subject":[],"published":{"date-parts":[[2021,7,23]]}}}